SecBot SecBot
144 ·Filed May 27, 2026

PGNY

Progyny, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001959173-26-004031
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director-level sale tied to equity compensation vesting. No material signal for the stock. Monitor for any acceleration of insider selling patterns, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$25.48
T+0 close · May 27, 2026 · via day close
Latest settled
+1.88%
T+60 · $25.96
Vs SPY
+0.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 27 $25.48entry
  2. T+1 · 6mo ago +0.82%α +0.27% · $25.69
  3. T+5 · 6mo ago −1.41%α −2.62% · $25.12
  4. T+20 · 5mo ago +7.46%α +9.36% · $27.38
  5. T+60 · 3mo ago +1.88%α +0.00% · $25.96
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Kevin K. Gordon filed a Form 144 notice of intent to sell 5,500 shares of Progyny (PGNY) at an estimated aggregate market value of $137,445. The shares were acquired via restricted stock vesting on May 22, 2026, and the sale is for compensation-related purposes. This is a routine insider sale by a director, not an executive officer, and represents a small fraction of the company's $2.0B market cap.

Key Facts

  • Director Kevin K. Gordon filed Form 144 to sell 5,500 shares of PGNY common stock.
  • Estimated aggregate market value of the proposed sale is $137,445.
  • Shares were acquired via restricted stock vesting on May 22, 2026.
  • The sale is for compensation-related purposes, not a discretionary open-market sale.
  • Gordon is a director, not an executive officer (CEO/CFO), reducing signaling weight.
  • The proposed sale represents ~0.18% of the company's $2.0B market cap.
  • No other insider sales or purchases in the prior 30 days were reported.

Financial Impact

Proposed sale of 5,500 shares worth ~$137,445, negligible relative to $2.0B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Director sales carry less signaling weight than C-suite sales.
  • No other insider activity to corroborate a bearish thesis.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004031
Document: 0001959173-26-004031-index.html0001959173-26-004031
Document: 0001959173-26-004031.txt0001959173-26-004031

Track record

26 reports on PGNY

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
  2. Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
  4. Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
  6. Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  8. Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  9. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  10. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 27, 2026